About Noel

Noel Ripberger-Scheick practices corporate and securities law, representing emerging companies at all stages of their life cycle, from early stage startups to public companies. Her experience includes representation of issuers and investors in venture capital and other private financings, buyers and sellers in mergers and acquisitions, and issuers and underwriters in public offerings, as well as general corporate, securities law and SEC periodic reporting compliance matters.

View full bio

Passions

Crafting and Gardening 

Being from the Midwest

My Dog, Arlo 

 

Experience

Dualitas Therapeutics Launches With $65 Million Series A

Dualitas Therapeutics Launches With $65 Million Series A

September 16, 2025

Cooley advised Dualitas, a biotechnology company pioneering next-generation bispecific antibody therapies for immunology and inflammation, on its $65 million Series A financing, to advance a portfolio of next-generation bispecific antibodies, including lead programs DTX-103 in allergic disease and DTX-102 for autoimmune disease, and to accelerate the development of Dualitas’ proprietary DualScreen BsAb discovery engine.

Read more

Related contacts

Sara Semnani
Partner, Santa Monica
Noel Ripberger-Scheick
Associate, Palo Alto
Sam Thompson
Associate, Santa Monica
Michael Aridi Barake
Associate, Santa Monica
Cameron Hajialiakbar
Associate, Santa Monica
Christy Fairlie
Paralegal Specialist, Reston
Jake Ironfield
Transactional Quantitative Analyst, New York
Dillon Martinson
Special Counsel, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Kristin O'Hanlon
Special Counsel, San Francisco
Annie Froehlich
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
John Sellers
Senior Counsel, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Kelley Harrington
Associate, Chicago
Shelby Saunders
Associate, New York

Related Practices & Industries

Emerging Companies
Biotechnology
Capital Markets
Tax
Compensation and Benefits
Life Sciences and Healthcare Regulatory
CFIUS

SiteOne Therapeutics to Be Acquired by Eli Lilly for up to $1 Billion

SiteOne Therapeutics to Be Acquired by Eli Lilly for up to $1 Billion

May 28, 2025

Cooley advised SiteOne Therapeutics, a private biotechnology company developing small molecule inhibitors of sodium channels to treat pain and other neuronal hyperexcitability disorders, on its acquisition by Eli Lilly.

Read more

Related contacts

Laura Berezin
Partner, Seattle
Sara Semnani
Partner, Santa Monica
Rowook Park
Partner, San Diego
Charity Williams
Partner, San Diego
Rena Kaminsky
Special Counsel, Palo Alto
Todd Gluth
Partner, San Diego
Lila Hope
Partner, Palo Alto
Noel Ripberger-Scheick
Associate, Palo Alto
Tucker Cochenour
Associate, Palo Alto
Kristin O'Hanlon
Special Counsel, San Francisco
David Fletcher
Partner, Washington, DC
Jamie Leigh
Partner, San Francisco
Carly Mitchell
Partner, Washington, DC
Jeremy Morrison
Partner, Washington, DC
Gerard O'Shea
Partner, New York
Marty Schenker
Senior Counsel , San Francisco
Andrew Epstein
Special Counsel, Seattle
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Selin Akkan
Associate, Palo Alto
Mari Dugas
Associate, Washington, DC
Virat Gupta
Associate, Washington, DC
Eileen Leman
Associate, Los Angeles
Joseph Perry
Associate, Reston
Hannah Rausch
Associate, New York
Melody Van Horn
Senior Paralegal, Palo Alto

Related Practices & Industries

Mergers and Acquisitions
Capital Markets
Life Sciences Corporate Partnering and Licensing
Life Sciences
Healthcare
Biotechnology
Compensation and Benefits
Cyber/Data/Privacy
Emerging Companies
Labor and Employment
Life Sciences and Healthcare Regulatory
Tax
Antitrust and Competition

SiteOne Therapeutics Announces $100 Million Series C

SiteOne Therapeutics Announces $100 Million Series C

December 18, 2024

Cooley advised SiteOne Therapeutics, a biopharmaceutical company developing selective ion channel modulators for the treatment of pain, cough and other conditions, on its $100 million Series C financing.

Read more

Related contacts

Laura Berezin
Partner, Seattle
Sara Semnani
Partner, Santa Monica
Noel Ripberger-Scheick
Associate, Palo Alto
Annie Froehlich
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Tracy Rubin
Partner, Palo Alto
John Sellers
Senior Counsel, Palo Alto
Denny Won
Partner, San Francisco
Kimberly Nguyen
Special Counsel, Reston
Kristin O'Hanlon
Special Counsel, San Francisco
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Michelle Liskanich
Associate, Santa Monica
Michael Gladstone
Associate, New York
Sarah Oliai
Associate, Washington, DC
Melody Van Horn
Senior Paralegal, Palo Alto
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

Life Sciences
Healthcare
Capital Markets
Emerging Companies
CFIUS
Cyber/Data/Privacy
Life Sciences and Healthcare Regulatory
Technology Transactions
Compensation and Benefits
Life Sciences Corporate Partnering and Licensing

Snap $750 Million Convertible Senior Notes Offering

Snap $750 Million Convertible Senior Notes Offering

May 13, 2024

Cooley advised Snap, a technology company, on its $750 million convertible senior notes offering due 2030, which includes the option for initial purchasers to purchase an additional $100 million aggregate principal amount of notes.

Read more

Related contacts

Eric Jensen
Senior Counsel, Palo Alto
David Peinsipp
Partner, San Francisco
Noel Ripberger-Scheick
Associate, Palo Alto
Alanna Anderson
Associate, Palo Alto
Victoria Comesañas
Associate, Los Angeles
Bill Boyle
Paralegal Specialist, Palo Alto
Francis Wheeler
Senior Counsel, Colorado

Related Practices & Industries

Emerging Companies
Capital Markets
Technology
Internet and Social Media

Openprise Secures $25 Million in Series B Funding

Openprise Secures $25 Million in Series B Funding

March 5, 2024

Cooley advised Openprise on its $25 million Series B financing led by investment funds managed by Morgan Stanley Expansion Capital. Partner Mark Medearis led the Cooley team advising Openprise, a top revenue operations (RevOps) data automation company using artificial intelligence to help RevOps teams transform their data into action, achieve operational agility at scale and simplify technology to drive efficient growth.

Related contacts

Mark Medearis
Senior Counsel, Palo Alto
Noel Ripberger-Scheick
Associate, Palo Alto
Christy Fairlie
Paralegal Specialist, Reston

Related Practices & Industries

Artificial Intelligence
Emerging Companies
Technology
Venture Capital
View more

Admissions and credentials

California

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.